Green Thumb Industries Inc.
Green Thumb Industries Inc. is a U.S.-based cannabis company that grows, processes, manufactures, distributes, and sells cannabis products through both branded consumer packaged goods and its own retail dispensaries. Founded in 2014 and headquartered in Chicago, it operates across 14 U.S. markets and combines cultivation, manufacturing, wholesale distribution, and retail under the RISE Dispensaries banner.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueSales of cannabis-related products through owned dispensaries, primarily under the RISE brand.
Branded cannabis products manufactured, distributed, and sold to third-party licensed retailers and company stores.
Customers
Green Thumb sells to two main customer groups: consumers and patients who shop its owned dispensaries, and licensed cannabis retailers that buy its branded products for resale. The company also serves adult-use and medical markets across its operating states, with demand shaped by local licensing, product availability, and state regulations.
Buy cannabis-related products at RISE and other stores for personal use, wellness, or medical needs.
Purchase Green Thumb-branded products for resale in state-licensed dispensaries.
Buy products in states where recreational cannabis is legal, supporting store traffic and basket growth.
Purchase regulated cannabis products for therapeutic use in medical programs.
Strategy
Green Thumb’s strategy centers on combining owned retail with branded product manufacturing to capture value across the cannabis supply chain. Management is focused on sustainable profitable growth, expanding within existing markets, and adding stores or partnerships when licensing and capital conditions allow.
More stores increase direct-to-consumer reach and improve control over merchandising and margins.
Branded products create repeat demand and diversify revenue beyond store traffic.
Cannabis markets remain competitive and regulated, so disciplined growth is needed to protect returns.
Geography
Green Thumb operates in 14 U.S. states, with revenue generated across California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, and Virginia. Its manufacturing footprint spans 13 states, while RISE dispensaries are present in all 14 markets, making state-level licensing and local regulation central to growth and operating flexibility.
Risks
Green Thumb faces regulatory, competitive, and operating risks typical of the cannabis industry, including state-by-state licensing constraints, unfavorable U.S. tax treatment, and competition from lower-priced unregulated products. Its vertically integrated model also exposes it to cultivation, product quality, and retail execution risks, while the company’s early-stage industry context and concentrated voting control add governance and execution uncertainty.
- Unfavorable tax treatmentImpact: HighLikelihood: High
Cannabis businesses may face significant tax burdens that compress margins and cash flow.
Exposure: After-tax earnings and liquidity
- Competition from unregulated productsImpact: HighLikelihood: High
Untaxed or untested products can be priced lower than regulated cannabis.
Exposure: Pricing power and market share
- Regulatory and licensing constraintsImpact: HighLikelihood: Medium
Cannabis operations depend on state approvals, local permissions, and changing rules.
Exposure - Agricultural and cultivation riskImpact: MediumLikelihood: Medium
The company grows cannabis, so pests, disease, climate control failures, and yield variability can affect supply.
Exposure: Production volumes and cost of goods sold
- Product liability and recallsImpact: MediumLikelihood: Medium
Cannabis products can trigger claims if quality, labeling, or safety issues arise.
Exposure
Accounting
Judgemental itemsSales occur through retail stores and wholesale channels, so timing differs by transaction type.
Impact: Affects reported revenue timing and comparability across periods
Cultivation, processing, packaging, and allocated facility costs flow into cost of goods sold.
Impact: Affects gross profit and margin volatility
Valuation depends on future cash flows, discount rates, and market conditions in a volatile industry.
Impact: Can create large non-cash charges
Dispensaries, cultivation sites, and manufacturing facilities are lease-intensive.
Impact: Affects balance sheet leverage and operating expense presentation
The 2025 sale of CPG brand IP and exclusive licensing requires judgment on gains and ongoing economics.
Impact: Affects other income, intangible assets, and future royalty/license expense
Similar listed companies
Publicly listed companies with a comparable business focus.
Edible Garden AG Inc
EDBLW · Agricultural Production-Crops
Edible Garden AG Inc grows and sells fresh herbs and vegetables, while also expanding into branded consumer products such as sauces, fermented products, flavor enhancers, and nutritional supplements.
Marimed Inc.
MRMD · Medicinal Chemicals & Botanical Products
Trulieve Cannabis Corp.
TRLV · Medicinal Chemicals & Botanical Products
Planet 13 Holdings Inc.
PLNH · Agricultural Production-Crops
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
Last updated: 24/09/2026